Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

265
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
265
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electroacupuncture modulates gut-lung microbiota and lung EMT to attenuate airway remodeling in COPD.

Frontiers in microbiology·2026
Same author

Glucagon-like peptide-1 receptor agonists across anti-inflammation.

Molecular aspects of medicine·2026
Same author

Autonomic nervous system dysfunction in chronic obstructive pulmonary disease: mechanistic insights and therapeutic implications.

Annals of medicine·2025
Same author

[Effect of electroacupuncture on intestinal flora in COPD rats based on gut-lung axis theory].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2025
Same author

Targeted Therapy Evolution from Defining a Sub-population to Crossing Multi-indications.

Advanced pharmaceutical bulletin·2025
Same author

Efficacy and Safety of Acupuncture in Managing COPD: An Overview of Systematic Reviews.

International journal of chronic obstructive pulmonary disease·2024

Related Experiment Video

Updated: Jan 9, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K

Heparin against inflammation: Targeting evolution and clinical impacts.

Daohong Chen1

  • 1Research Institute, Changshan Biochemical Pharmaceutical, 71 Menglong Street, Zhengding New District, Shijiazhuang, 050800 Hebei, China.

Annales Pharmaceutiques Francaises
|December 3, 2025
PubMed
Summary

Heparin offers broad therapeutic potential beyond anticoagulation due to its complex structure. This review highlights heparin

Keywords:
Effets non anticoagulantsHeparinHéparineNon-anticoagulant effectsThrombo-inflammation

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.6K

Related Experiment Videos

Last Updated: Jan 9, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

12.1K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.3K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.6K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Immunology

Background:

  • Heparin's complex polysaccharide structure enables interactions with diverse bioactive molecules, leading to effects beyond anticoagulation.
  • Thrombo-inflammation involves complex interactions, presenting opportunities for novel therapeutic strategies.
  • Heparin's anti-inflammatory properties are increasingly recognized, suggesting expanded clinical applications.

Purpose of the Study:

  • To provide a comprehensive clinical profile of inflammatory disorders benefiting from heparin.
  • To explore heparin's multifaceted pharmacological effects in managing thrombo-inflammation.
  • To bridge the gap between heparin's biological mechanisms and its clinical use in inflammatory conditions.

Main Methods:

  • Systematic review of clinical data and scientific literature on heparin's role in inflammatory disorders.
  • Analysis of heparin's multi-targeting mechanisms against thrombo-inflammation.
  • Compilation of evidence for heparin administration in conditions such as sepsis, pregnancy, pulmonary disease, pancreatitis, nephropathy, and skin disorders.

Main Results:

  • Heparin demonstrates significant therapeutic potential in managing a range of inflammatory conditions.
  • Multiple targeting mechanisms contribute to heparin's anti-inflammatory and anti-thrombo-inflammatory effects.
  • Clinical applications of heparin in inflammatory indications are expanding, though often based on empirical evidence.

Conclusions:

  • Heparin possesses multifaceted pharmacological effects applicable to various inflammatory disorders.
  • Further research is warranted to fully elucidate heparin's mechanisms and optimize its use in treating inflammation.
  • Heparin represents a promising therapeutic agent for managing thrombo-inflammation and related inflammatory conditions.